Pluri Inc. Insider Trading

PLUR

⊜ Compare

Last 12 months

Insiders bought $1.25M on the open market and sold nothing.

Net open-market

+$1.25M

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Oct 2026

Oct 23, 2026

Get an email when PLUR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 23	Alexandre Weinstein Manieu Director	Bought	833,334	$1.50	$1.25M	66%	Form 4
Apr 28, 2025	Alexandre Weinstein Manieu Director	Bought	452,702	$4.61	$2.09M	23%	Form 4
Apr 28, 2025	Chutzpah Holdings Ltd Large holder	Bought 2 parts	976,139	$4.61 average	$4.5M	233%	Form 4

Oct 23
Alexandre Weinstein Manieu
Director · bought 833,334 at $1.50
$1.25M
66% of stake
Apr 28, 2025
Alexandre Weinstein Manieu
Director · bought 452,702 at $4.61
$2.09M
23% of stake
Apr 28, 2025
Chutzpah Holdings Ltd
Large holder · bought 976,139 at avg $4.61
$4.5M
233% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PLUR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PLUR

CompareIntrinsic value

PROKProKidney Corp

$1.12+4.67%10

IMAImageneBio, Inc.

$4.10+1.99%10

INBXInhibrx Biosciences, Inc.

$86.76+7.01%15

SCNIScinai Immunotherapeutics Ltd.

$0.45-4.92%30

SABSSab Biotherapeutics Inc.

$3.18+1.92%19

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

CRDFCardiff Oncology Inc.

$0.87+1.03%36

PALIPalisade Bio Inc.

$1.25+1.63%20

Spot a number that looks wrong? Check it in PLUR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PLUR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.